Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Observation of Combined Immunization of COVID-19 Inactivated Vaccine With Quadrivalent Influenza Vaccine(QIV) and 23-valent Pneumococcal Polysaccharide Vaccine

NCT05298800 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention, China as lead sponsor.

NCT NCT05298800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05298800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Observation of Combined Immunization of COVID-19 Inactivated Vaccine With Quadrivalent Influenza Vaccine(QIV) and 23-valent Pneumococcal Polysaccharide Vaccine
Lead sponsor
Centers for Disease Control and Prevention, China
Phase
Phase 4
Overall status
Unknown status
Start date
October 8, 2021
Completion date
December 31, 2023
Enrollment
3,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 vaccines, immunogenicity, vaccine, influenza vaccines, pneumococcal vaccines, safety